Dr. Reddy’s API plant in Hyderabad gets VAI classification from U.S. FDA
The Hindu
Dr. Reddy's Laboratories API facility in Hyderabad classified as VAI by U.S. FDA after inspection.
An active pharmaceutical ingredients (API) manufacturing facility of Dr. Reddy’s Laboratories in Hyderabad inspected last year by the United States Food and Drug Administration (U.S. FDA) has since been classified as Voluntary Action Indicated (VAI) by the agency.
“The U.S. FDA has classified the inspection as VAI and concluded that the inspection is closed...,” the generic drugmaker on Tuesday (February 25, 2025) said in an update to the stock exchanges on the inspection of the API manufacturing facility (CTO-2) in Bollaram, Hyderabad.
The U.S. FDA had conducted the GMP inspection from November 13-19 and issued a Form 483 with seven observations to the facility.
Prime Minister Modi to inaugurate Advantage Assam 2.0 Summit with industry leaders and foreign delegates present.
Indian pharma companies urged to diversify beyond U.S. market due to potential 25% tariff, focusing on global expansion for growth.
Equity indices rebound in early trade amid value buying, Sensex up 117.57 points, Nifty up 31.3 points.
rupee vs dollar rupee updates on February 25, 2025
Delhi High Court rules on pilot duty norms, with changes effective from July 1, 2025, addressing fatigue and rest concerns.
EU and U.K. impose new sanctions on Russian entities, impacting Indian companies, in response to Ukraine conflict.
RBI allows withdrawal of up to ₹25,000 per depositor of New India Co-operative Bank from February 27
RBI relaxes restrictions on New India Co-operative Bank, allowing depositors to withdraw up to ₹25,000 from February 27.
Finance Ministry briefs Lok Sabha Select Committee on new Income Tax Bill, aiming to simplify language and improve user-friendliness.
Gold prices rise to near record high of ₹89,100 per 10 grams, driven by geopolitical tensions and weak dollar.
BSE Sensex falls over 1% below 75,000 amid US tariff concerns, foreign fund outflows, and global market trends.
India and the U.K. aim to strengthen trade ties through balanced and ambitious free trade agreement negotiations.
NCLAT reserves order on CDEL appeal, leading to resumption of insolvency process for Coffee Day Enterprises Ltd.
Prime Minister Modi highlights India's economic growth potential and investment opportunities at Madhya Pradesh Global Investors Summit.